Oxford Diffraction recently held its annual EU user meeting at its UK headquarters in Yarnton, Oxford...

To coincide with the opening of our new UK demonstration facilities and the recent launch of the SuperNova product, Oxford Diffraction will be hosting a Europe region user meeting during the 8th and 9th December.

Oxford Diffraction have designed a web based user forum to provide their global users with a resource for the exchange of ideas and tips relating to their X-ray diffraction systems, and to encourage scientific collaborations and crystallographic discussion.

Oxford, UK - Oxford Diffraction, Now a part of Varian, Inc. (NasdaqGS: VARI) introduced its new dual wavelength X-ray diffractometer for the analysis of small molecules and proteins. The SuperNova is the first dual wavelength diffraction system to use entirely high intensity micro-source X-ray technology. It includes innovations in both X-ray technology and data analysis, enabling faster results even for the most challenging crystals.

The Randall Division of Cell and Molecular Biophysics at King's College London have confirmed their investment in an Oxford Diffraction PX Scanner and an Xcalibur Nova system.

Oxford Diffraction continues to innovate and push the boundaries in everything we do. This time we're running a 'Live' demo of our in situ X-ray diffraction product PX Scanner. From the 21st July until the 25th, we'll have a 'working' PX Scanner on our exhibition booth no. 203 at the American Crystallographic Association (ACA) annual meeting in Salt Lake City, Utah.

The all new Atlas CCD detector from Oxford Diffraction is the ideal detector for high speed, high resolution data collections on small molecules. As the fastest commercially available CCD detector the Atlas is up to 3.5 times faster than other CCD detectors.

Guests from the Martinsried Max Planck Institutes mingled with structural biologists from the nearby research centres in both Munich (Gene Center, Technical University and GSF) and T-bingen, as well as with representatives of local companies from the Martinsried Biotech campus.

Palo Alto, CA - Varian, Inc. (NasdaqGS: VARI) announced today that it has acquired Oxford Diffraction, Ltd., a privately owned company based in Abingdon, U.K. Oxford Diffraction is a leader in x-ray crystallography, an analytical technique used by scientists in pharmaceutical research and other research laboratories to determine the structure of both small molecules and large molecules such as proteins.

Following the announcement of the $787 billion funding package by President Obama, these key facts relate to the allocation for scientific research...